Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease-Reference-Cited by-同舟云学术

Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease

Published:2010-07-28 Issue:13 Volume:25 Page:2156-2163
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov. Disord.

Author:

Aasly Jan O.,Vilariño-Güell Carles,Dachsel Justus C.,Webber Philip J.,West Andrew B.,Haugarvoll Kristoffer,Johansen Krisztina K.,Toft Mathias,Nutt John G.,Payami Haydeh,Kachergus Jennifer M.,Lincoln Sarah J.,Felic Amela,Wider Christian,Soto-Ortolaza Alexandra I.,Cobb Stephanie A.,White Linda R.,Ross Owen A.,Farrer Matthew J.

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/mds.23265/fullpdf

Reference22 articles.

1. Epidemiology of Parkinson's disease;de Lau;Lancet Neurol,2006

2. Genetics of Parkinson disease: paradigm shifts and future prospects;Farrer;Nat Rev Genet,2006

3. Bagade S Lill C McQueen M The PDGene database Alzheimer Research Forum 2009

4. LRRK2 in Parkinson's disease: protein domains and functional insights;Mata;Trends Neurosci,2006

5. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity;West;Hum Mol Genet,2007

Cited by 105 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How Parkinson’s Disease-Linked LRRK2 Mutations Affect Different CNS Cell Types;Journal of Parkinson's Disease;2024-06-15

2. Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice;npj Parkinson's Disease;2023-12-18

3. An Overview of the Worldwide Distribution of LRRK2 Mutations in Parkinson’s Disease;Neurodegenerative Disease Management;2023-12

4. Clinical biomarkers for Lewy body diseases;Cell & Bioscience;2023-11-14

5. An Update on the Interplay between LRRK2, Rab GTPases and Parkinson’s Disease;Biomolecules;2023-11-13